Credit Suisse Downgrades New Frontier Health (NFH) to Neutral
Tweet
Share
E-mailGet Alerts NFH Hot Sheet
Price: $11.95 --0%
Rating Summary:
0 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
0 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Credit Suisse analyst Jason Liu downgraded New Frontier Health (NYSE: NFH) from Outperform to Neutral with a price target of $12.00 (from $12.00).
For an analyst ratings summary and ratings history on New Frontier Health click here. For more ratings news on New Frontier Health click here.
Shares of New Frontier Health closed at $11.21 yesterday.
You May Also Be Interested In
- Jefferies Downgrades Calix (CALX) to Hold
- Nomura/Instinet Downgrades ICICI Prudential Life Insurance Co Ltd. (IPRU:IN) to Neutral
- Stifel Downgrades HashiCorp Inc (HCP) to Hold
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
